Cargando…
D1398G Variant of MET Is Associated with Impaired Signaling of Hepatocyte Growth Factor in Alveolar Epithelial Cells and Lung Fibroblasts
Pulmonary fibrosis represents the terminal stage of a diverse group of lung diseases including scleroderma associated interstitial lung disease. The molecular mechanisms underlying the pathogenesis of lung fibrosis are not well understood and there is a great need for more effective treatment for th...
Autores principales: | Atanelishvili, Ilia, Shirai, Yuichiro, Akter, Tanjina, Noguchi, Atsushi, Ash, Kurt T., Misra, Suniti, Ghatak, Sibnath, Silver, Richard M., Bogatkevich, Galina S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008815/ https://www.ncbi.nlm.nih.gov/pubmed/27584154 http://dx.doi.org/10.1371/journal.pone.0162357 |
Ejemplares similares
-
Establishment of an indirect ELISA for detection of the novel antifibrotic peptide M10
por: Akter, Tanjina, et al.
Publicado: (2017) -
The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects
por: Bogatkevich, Galina S., et al.
Publicado: (2012) -
Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery
por: Misra, Suniti, et al.
Publicado: (2015) -
Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis
por: Ghatak, Shibnath, et al.
Publicado: (2015) -
Anales de Tecamachalco, 1398-1590
Publicado: (1992)